{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:47:39Z","timestamp":1778917659145,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001755","name":"Mesothelioma Applied Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005348","name":"American Association for Thoracic Surgery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jtcvs.2022.11.035","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T11:40:22Z","timestamp":1671018022000},"page":"1722-1730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy"],"prefix":"10.1016","volume":"165","author":[{"given":"R. Taylor","family":"Ripley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hudson M.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S.","family":"Whitlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn S.","family":"Groth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian G.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene A.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan M.","family":"Burt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H.","family":"Sugarbaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2022.11.035_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/2049396712Y.0000000016","article-title":"Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008","volume":"19","author":"Henley","year":"2013","journal-title":"Int J Occup Environ Health"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib2","first-page":"935","article-title":"Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005","volume":"20","author":"Moolgavkar","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/aje\/kwh025","article-title":"Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003","volume":"159","author":"Price","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/CEJ.0b013e3282f0c0a2","article-title":"US mesothelioma patterns 1973-2002: indicators of change and insights into background rates","volume":"17","author":"Teta","year":"2008","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib6","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2009.08.019","article-title":"Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin\/pemetrexed and radiotherapy","volume":"71","author":"Bolukbas","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib9","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1200\/JCO.2016.67.2675","article-title":"Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma","volume":"34","author":"Rimner","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib10","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jtcvs.2012.12.037","article-title":"Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection","volume":"145","author":"Sugarbaker","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 5","key":"10.1016\/j.jtcvs.2022.11.035_bib12","doi-asserted-by":"crossref","first-page":"v31","DOI":"10.1093\/annonc\/mdv199","article-title":"Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Baas","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.6004\/jnccn.2016.0087","article-title":"NCCN guidelines insights: malignant pleural mesothelioma, version 3.2016","volume":"14","author":"Ettinger","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib15","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jtho.2018.08.001","article-title":"Surgery in malignant pleural mesothelioma","volume":"13","author":"Bueno","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jtho.2019.04.029","article-title":"A proposed system toward standardizing surgical-based treatments for malignant pleural mesothelioma, from the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation taskforce","volume":"14","author":"Friedberg","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib17","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","volume":"6","author":"Rice","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.thorsurg.2020.07.002","article-title":"Extended pleurectomy and decortication for malignant pleural mesothelioma","volume":"30","author":"Ripley","year":"2020","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.xjtc.2021.01.044","article-title":"Extended pleurectomy and decortication: video atlas of operative steps","volume":"7","author":"Ripley","year":"2021","journal-title":"JTCVS Tech"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1245\/s10434-008-0219-1","article-title":"Diffuse malignant peritoneal mesothelioma: failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"16","author":"Baratti","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib21","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/cncr.32870","article-title":"The Chicago Consensus on peritoneal surface malignancies: management of peritoneal mesothelioma","volume":"126","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejso.2020.02.011","article-title":"Peritoneal mesothelioma: PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"47","author":"Kusamura","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.21037\/tlcr.2018.08.03","article-title":"Update on the management of malignant peritoneal mesothelioma","volume":"7","author":"Sugarbaker","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1245\/s10434-019-07409-5","article-title":"50 Patients with malignant mesothelioma of both the pleura and\u00a0peritoneum: a single-institution experience","volume":"27","author":"Letica-Kriegel","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1159\/000136800","article-title":"Response of a patient with pleural and peritoneal mesothelioma after second-line chemotherapy with lipoplatin and gemcitabine","volume":"73","author":"Karpathiou","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/JTO.0b013e3181989551","article-title":"Malignant pleural and peritoneal mesothelioma: incidental diagnosis and excellent treatment results","volume":"4","author":"Miliauskas","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib27","first-page":"2484","article-title":"Synchronous pleural and peritoneal malignant mesothelioma: a case report and review of literature","volume":"7","author":"Del Gobbo","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.thorsurg.2020.07.001","article-title":"The staging of malignant pleural mesothelioma","volume":"30","author":"Euhus","year":"2020","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.athoracsur.2014.09.056","article-title":"Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma","volume":"99","author":"Taioli","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib30","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1097\/JTO.0b013e3182288af9","article-title":"Pleurectomy\/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma","volume":"6","author":"Lang-Lazdunski","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib31","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the international association for the study of lung cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib33","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.athoracsur.2020.08.113","article-title":"Diagnostic laparoscopy improves staging of malignant pleural mesothelioma with routine positron emission tomography imaging","volume":"112","author":"Ripley","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib34","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1245\/s10434-021-10048-4","article-title":"Cytoreductive surgery plus HIPEC with and without NIPEC for malignant peritoneal mesothelioma: a propensity-matched analysis","volume":"28","author":"Sugarbaker","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib35","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/ejcts\/ezv403","article-title":"The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy\/decortication","volume":"49","author":"Sharkey","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2022.11.035_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.athoracsur.2021.04.078","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication for malignant pleural mesothelioma","volume":"113","author":"Zhou","year":"2022","journal-title":"Ann Thorac Surg"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522322013381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522322013381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T17:20:54Z","timestamp":1758388854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522322013381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0022522322013381"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2022.11.035","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2022.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}